FDA
approval
· 2022-06-22
FDA Approved: PEMETREXED — Original Application (Hospira, Inc.)
Summary
FDA approved Hospira, Inc.'s original application for pemetrexed (injectable), authorizing a generic pemetrexed product with the established cancer indications.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PEMETREXED (PEMETREXED)